First Trust NASDAQ 100 Technology Index Fund (QTEC) Stock Price Today
Aura AI Summary
Key Stats
- $4.81BMarket Cap
- 2,609,368Volume
- Broad Market / FactorSector
- $335.7452W High
- $207.0352W Low
- 39 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- 100% Sell | 0% BuyTrading Activity
Track First Trust NASDAQ 100 Technology Index Fund (QTEC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, First Trust NASDAQ 100 Technology Index Fund has traded between a low of $207.03 and a high of $335.74, highlighting its annual price range. Buy and sell First Trust NASDAQ 100 Technology Index Fund shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About First Trust NASDAQ 100 Technology Index Fund
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Most Recent News
Several high-volume stocks plunge sharply amid profit-taking despite positive updates.
Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.
Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.
Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.